Literature DB >> 8579960

In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats.

J E Onyia1, J Bidwell, J Herring, J Hulman, J M Hock.   

Abstract

Intermittent PTH increases trabecular bone mass in vivo by stimulating osteoblast differentiation to increase bone formation. The molecular events that mediate the anabolic effect of PTH on osteoblasts have not been characterized. We investigated if PTH regulated mRNA expression of proto-oncogenes, c-fos, c-jun, and c-myc, early response genes that have been shown to be involved in the regulation of both cell proliferation and differentiation. As PTH also regulates the early expression of the cytokine, interleukin-6 (IL-6), in bone cells in vitro, we also investigated if this occurred in vivo, in concert with the other early response genes. Northern blot hybridization was used to analyze mRNA expression in the metaphysis of the distal femur of young rats. To determine the proliferative state in these femurs, mRNA expression of the cell proliferation marker histone, H4, was assessed. Subcutaneous administration of a single injection of human PTH (1-34) at 8 micrograms/100 g, a dose known to increase bone forming surfaces, induced rapid and transient expression of c-fos, c-jun, c-myc, and IL-6 mRNA. A second novel transcript for IL-6 was detected, but its significance remains unknown. Induction of all these messages was evident by 1 h; the levels of mRNA returned to baseline after 3-6 h. Concurrently, PTH had a small inhibitory effect on the expression of histone H4 mRNA. We conclude that, in vivo, PTH upregulates cell differentiation in trabecular bone by transient stimulation of the early response genes and IL-6, while downregulating cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8579960     DOI: 10.1016/8756-3282(95)00332-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  21 in total

Review 1.  Stemming bone loss by suppressing apoptosis.

Authors:  J M Hock
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells.

Authors:  Chad M Novince; Amy J Koh; Megan N Michalski; Julie T Marchesan; Jason Wang; Younghun Jung; Janice E Berry; Matthew R Eber; Thomas J Rosol; Russell S Taichman; Laurie K McCauley
Journal:  Am J Pathol       Date:  2011-09-21       Impact factor: 4.307

3.  Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone.

Authors:  Sun Wook Cho; Fabiana N Soki; Amy J Koh; Matthew R Eber; Payam Entezami; Serk In Park; Nico van Rooijen; Laurie K McCauley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-09       Impact factor: 11.205

Review 4.  Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.

Authors:  J Y Reginster; A N Taquet; G Fraikin; C Gosset; B Zegels
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

5.  The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone.

Authors:  Sun Wook Cho; Flavia Q Pirih; Amy J Koh; Megan Michalski; Matthew R Eber; Kathryn Ritchie; Benjamin Sinder; Seojin Oh; Saja A Al-Dujaili; JoonHo Lee; Ken Kozloff; Theodora Danciu; Thomas J Wronski; Laurie K McCauley
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

6.  Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts.

Authors:  Sang Wan Kim; Paola Divieti Pajevic; Martin Selig; Kevin J Barry; Jae-Yeon Yang; Chan Soo Shin; Wook-Young Baek; Jung-Eun Kim; Henry M Kronenberg
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

7.  Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone.

Authors:  L M Calvi; N A Sims; J L Hunzelman; M C Knight; A Giovannetti; J M Saxton; H M Kronenberg; R Baron; E Schipani
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

8.  Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment.

Authors:  Julie M Quach; Emma C Walker; Elizabeth Allan; Melissa Solano; Atsushi Yokoyama; Shigeaki Kato; Natalie A Sims; Matthew T Gillespie; T John Martin
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

9.  A fracture does not adversely affect bone mineral density responses after teriparatide treatment.

Authors:  Aasis Unnanuntana; Quang V Ton; John P Kleimeyer; Joseph T Nguyen; Joseph M Lane
Journal:  Clin Orthop Relat Res       Date:  2011-08-24       Impact factor: 4.176

10.  Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate.

Authors:  R A Wermers; C P Recknor; F Cosman; L Xie; E V Glass; J H Krege
Journal:  Osteoporos Int       Date:  2008-02-19       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.